Viragova, S., Aparicio, L., Palmerini, P., Zhao, J., Valencia Salazar, L. E., Schurer, A., Dhuri, A., Sahoo, D., Moskaluk, C. A., Rabadan, R., & Dalerba, P. (2023). Inverse agonists of retinoic acid receptor/retinoid X receptor signaling as lineage-specific antitumor agents against human adenoid cystic carcinoma. JNCI: Journal of the National Cancer Institute, 115(7), 838–852. https://doi.org/10.1093/jnci/djad062
Subjects:
Grants:
P30CA013696
(NIH – National Cancer Institute)
R35CA253126
(NIH – National Cancer Institute)
U01CA261822
(NIH – National Cancer Institute)
UG3TR003355
(NIH – National Center for Advancing Translational Sciences)
TL1TR001875
(NIH – National Center for Advancing Translational Sciences)
UL1TR001873
(NIH – National Center for Advancing Translational Sciences)
R01AI155696
(NIH – National Institute of Allergy and Infectious Diseases)
R01DE028961
(NIH – National Institute of Dental & Craniofacial Research)
RC1DE020687
(NIH – National Institute of Dental & Craniofacial Research)
R01GM138385
(NIH – National Institute of General Medical Sciences)
T32GM008224
(NIH – National Institute of General Medical Sciences)
Publication Type:
Article
Unique ID:
10.1093/jnci/djad062
PMID:
DOI:
Publication Date:
Data Source:
PubMed
Source Link: